Cresco Labs is trading 6.06% down at $0.62 on October 2, 2026, as cannabis stocks sink amid reports of a federal rescheduling delay.
- A DEA judge paused proceedings while considering whether to add a Government Accountability Office report to the record.
- No new Cresco Labs-specific announcement was found for October 2.
- The decline stands out against rising broad-market indices.